Skip to main content
Equibles
AORT logo

AORT · Artivion, Inc. · Metrics

Track AORT — free

Use AORT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AORT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$24.09 +1.19 (+5.17%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.12B
Shares
48.76M
Volume · Oct 22 122.1K Avg daily vol (3M) 633.97K

AORT metrics

104 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$22.90
Market cap
$1.12B

Price action

20 metrics
Price change (1W)
+6.4%
Price change (30D)
-5.1%
Price change (3M)
-8.9%
Price change (6M)
-38.2%
Price change (YTD)
-49.8%
Price change (1Y)
-45.9%
Trailing year
Price change (5Y)
+8.6%
52-week high
$47.63
52-week low
$20.10
Change from 52-week high
-51.9%
Change from 52-week low
+13.9%
Annualized volatility
48.5%
Annualized volatility (3M)
36.9%
Beta
0.3
RSI (14D)
50.3
Price vs SMA 50
-7.0%
Price vs SMA 200
-24.0%
Avg volume (3M)
633,972
Relative volume
0.8
Average dollar volume
$16.09M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
48.76M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 33.5%
EV / EBITDA
31.1×
reciprocal yield 3.2%
EV / EBIT
68.2×
reciprocal yield 1.5%
P / sales
2.4×
reciprocal yield 42.1%
P / book
2.5
reciprocal yield 39.8%
FCF yield
-0.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
26.9
reciprocal yield 3.7%
Earnings yield
-0.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.7×
reciprocal yield 26.8%
EV / revenue historical average (5Y)
3.5×
reciprocal yield 28.9%
EV / EBIT historical average (3Y)
77.7×
reciprocal yield 1.3%
EV / EBIT historical average (5Y)
156.6×
reciprocal yield 0.6%
EV / EBITDA historical average (3Y)
32.1×
reciprocal yield 3.1%
EV / EBITDA historical average (5Y)
33.2×
reciprocal yield 3.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
64.4%
Operating margin
4.4%
Trailing 12 months
Net margin
-0.7%
Gross profit (TTM)
$303.50M
Operating profit (TTM)
$20.64M
Net income (TTM)
−$3.17M
Trailing 12 months
Diluted EPS (TTM)
$-0.06
FCF margin
-1.9%
Effective tax rate
241.7%

Per share

11 metrics
Revenue per diluted share (TTM)
$9.48
Gross profit per diluted share (TTM)
$6.10
Operating profit per diluted share (TTM)
$0.41
EBITDA per diluted share (TTM)
$0.90
Net income per diluted share (TTM)
$-0.07
Operating cash flow per diluted share (TTM)
$0.83
Free cash flow per diluted share (TTM)
$-0.18
Capital expenditures per diluted share (TTM)
$1.00
R&D per diluted share (TTM)
$0.70
Stock compensation per diluted share (TTM)
$0.54
Book value per share
$6.80

Growth

11 metrics
Revenue growth YoY
+11.3%
Year over year
Net income growth YoY
-1,104.5%
Revenue (TTM)
$471.47M
Trailing 12 months
EPS growth YoY
-1,033.3%
Shares change YoY
+7.0%
Year over year · more shares
Revenue CAGR (3Y)
+12.0%
Revenue CAGR (5Y)
+11.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-30.1%

Quality

14 metrics
Return on equity
-0.7%
Return on assets
-0.3%
Debt / equity
0.8
Current ratio
3.5
EBITDA (TTM)
$45.20M
Free cash flow (TTM)
−$9.16M
Quick ratio
2.5
Interest coverage
0.9
Net debt / EBITDA
6.3
Return on invested capital
—
Trailing 12 months
Net cash
−$286.11M
Latest balance sheet
Cash & equivalents
$77.32M
Total assets
$1.07B
Total debt
$363.42M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$41.71M
Capital expenditures (TTM)
$50.87M
R&D (TTM)
$35.10M
SG&A (TTM)
$254.77M
Stock compensation (TTM)
$26.80M
R&D / revenue
7.4%
Stock compensation / revenue
5.7%

Ownership (13F)

9 metrics
13F filers
206
13F filer change QoQ
-33
Institutional ownership
94.2%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
31.2%
Private-fund adviser ownership
24.8%
Active holders' share change QoQ
+2.3%
Holder tenure
13.7
Price vs estimated holder cost
-23.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.4%

Short interest

3 metrics
Short interest
7.4%
Latest settlement · 5.5 days to cover
Days to cover
5.5d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.60M
Insider-sentiment score
13 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 784199 CUSIP 228903100 13F (30d) 23 filings 23 filers Visit website Investor relations